Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Clover's profitability metrics are improving but remain dismal, while the firm appears to lack strong, competitive advantages. As a result, CLOV stock is a sell.

The post Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell appeared first on InvestorPlace.

• Get in Now on Tiny $3 ‘Forever Battery’ Stock
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.
• Stock Prodigy Who Found NIO at $2… Says Buy THIS
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”